306 related articles for article (PubMed ID: 33763657)
21. A Novel Prognostic Signature of mRNA-lncRNA in Breast Cancer.
Liu Q; Wang Z; Kong X; Wang X; Qi Y; Gao R; Fang Y; Wang J
DNA Cell Biol; 2020 Apr; 39(4):671-682. PubMed ID: 32040341
[TBL] [Abstract][Full Text] [Related]
22. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Gene Expression Signatures for the Identification of Cellular Heterogeneity in the Developing Mammary Gland.
Henry S; Trousdell MC; Cyrill SL; Zhao Y; Feigman MJ; Bouhuis JM; Aylard DA; Siepel A; Dos Santos CO
J Mammary Gland Biol Neoplasia; 2021 Mar; 26(1):43-66. PubMed ID: 33988830
[TBL] [Abstract][Full Text] [Related]
24. Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.
Fumagalli D; Blanchet-Cohen A; Brown D; Desmedt C; Gacquer D; Michiels S; Rothé F; Majjaj S; Salgado R; Larsimont D; Ignatiadis M; Maetens M; Piccart M; Detours V; Sotiriou C; Haibe-Kains B
BMC Genomics; 2014 Nov; 15(1):1008. PubMed ID: 25412710
[TBL] [Abstract][Full Text] [Related]
25. Cold-inducible RNA binding protein promotes breast cancer cell malignancy by regulating Cystatin C levels.
Indacochea A; Guerrero S; Ureña M; Araujo F; Coll O; LLeonart ME; Gebauer F
RNA; 2021 Feb; 27(2):190-201. PubMed ID: 33172965
[TBL] [Abstract][Full Text] [Related]
26. Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity.
Nguyen QH; Pervolarakis N; Blake K; Ma D; Davis RT; James N; Phung AT; Willey E; Kumar R; Jabart E; Driver I; Rock J; Goga A; Khan SA; Lawson DA; Werb Z; Kessenbrock K
Nat Commun; 2018 May; 9(1):2028. PubMed ID: 29795293
[TBL] [Abstract][Full Text] [Related]
27. Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.
Liu JC; Voisin V; Bader GD; Deng T; Pusztai L; Symmans WF; Esteva FJ; Egan SE; Zacksenhaus E
Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5832-7. PubMed ID: 22460789
[TBL] [Abstract][Full Text] [Related]
28. Human breast progenitor cell numbers are regulated by WNT and TBX3.
Arendt LM; St Laurent J; Wronski A; Caballero S; Lyle SR; Naber SP; Kuperwasser C
PLoS One; 2014; 9(10):e111442. PubMed ID: 25350852
[TBL] [Abstract][Full Text] [Related]
29. Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype.
Valdés-Mora F; Salomon R; Gloss BS; Law AMK; Venhuizen J; Castillo L; Murphy KJ; Magenau A; Papanicolaou M; Rodriguez de la Fuente L; Roden DL; Colino-Sanguino Y; Kikhtyak Z; Farbehi N; Conway JRW; Sikta N; Oakes SR; Cox TR; O'Donoghue SI; Timpson P; Ormandy CJ; Gallego-Ortega D
Cell Rep; 2021 Apr; 35(2):108945. PubMed ID: 33852842
[TBL] [Abstract][Full Text] [Related]
30. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
31. BRCA1 regulates human mammary stem/progenitor cell fate.
Liu S; Ginestier C; Charafe-Jauffret E; Foco H; Kleer CG; Merajver SD; Dontu G; Wicha MS
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1680-5. PubMed ID: 18230721
[TBL] [Abstract][Full Text] [Related]
32. Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
Skarlos P; Christodoulou C; Kalogeras KT; Eleftheraki AG; Bobos M; Batistatou A; Valavanis C; Tzaida O; Timotheadou E; Kronenwett R; Wirtz RM; Kostopoulos I; Televantou D; Koutselini E; Papaspirou I; Papadimitriou CA; Pectasides D; Gogas H; Aravantinos G; Pavlidis N; Arapantoni P; Skarlos DV; Fountzilas G
Cancer Chemother Pharmacol; 2012 Feb; 69(2):533-46. PubMed ID: 21901395
[TBL] [Abstract][Full Text] [Related]
33. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.
Shehata M; Teschendorff A; Sharp G; Novcic N; Russell IA; Avril S; Prater M; Eirew P; Caldas C; Watson CJ; Stingl J
Breast Cancer Res; 2012 Oct; 14(5):R134. PubMed ID: 23088371
[TBL] [Abstract][Full Text] [Related]
35. Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia.
Gudjonsson T; Adriance MC; Sternlicht MD; Petersen OW; Bissell MJ
J Mammary Gland Biol Neoplasia; 2005 Jul; 10(3):261-72. PubMed ID: 16807805
[TBL] [Abstract][Full Text] [Related]
36. Mammary epithelial cells have lineage-rooted metabolic identities.
Mahendralingam MJ; Kim H; McCloskey CW; Aliar K; Casey AE; Tharmapalan P; Pellacani D; Ignatchenko V; Garcia-Valero M; Palomero L; Sinha A; Cruickshank J; Shetty R; Vellanki RN; Koritzinsky M; Stambolic V; Alam M; Schimmer AD; Berman HK; Eaves CJ; Pujana MA; Kislinger T; Khokha R
Nat Metab; 2021 May; 3(5):665-681. PubMed ID: 34031589
[TBL] [Abstract][Full Text] [Related]
37. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
38. Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast.
Prasad M; Kumar B; Bhat-Nakshatri P; Anjanappa M; Sandusky G; Miller KD; Storniolo AM; Nakshatri H
Mol Cancer Res; 2019 Jul; 17(7):1556-1570. PubMed ID: 30992305
[TBL] [Abstract][Full Text] [Related]
39. Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.
Honeth G; Lombardi S; Ginestier C; Hur M; Marlow R; Buchupalli B; Shinomiya I; Gazinska P; Bombelli S; Ramalingam V; Purushotham AD; Pinder SE; Dontu G
Breast Cancer Res; 2014 May; 16(3):R52. PubMed ID: 24887554
[TBL] [Abstract][Full Text] [Related]
40. Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.
Choudhury S; Almendro V; Merino VF; Wu Z; Maruyama R; Su Y; Martins FC; Fackler MJ; Bessarabova M; Kowalczyk A; Conway T; Beresford-Smith B; Macintyre G; Cheng YK; Lopez-Bujanda Z; Kaspi A; Hu R; Robens J; Nikolskaya T; Haakensen VD; Schnitt SJ; Argani P; Ethington G; Panos L; Grant M; Clark J; Herlihy W; Lin SJ; Chew G; Thompson EW; Greene-Colozzi A; Richardson AL; Rosson GD; Pike M; Garber JE; Nikolsky Y; Blum JL; Au A; Hwang ES; Tamimi RM; Michor F; Haviv I; Liu XS; Sukumar S; Polyak K
Cell Stem Cell; 2013 Jul; 13(1):117-30. PubMed ID: 23770079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
